Additional Proxy Soliciting Materials (definitive) (defa14a)
April 27 2020 - 5:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
Payment of Filing Fee (Check the appropriate box):
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of
Proxy Materials for the Stockholder Meeting to Be Held on June 11, 2020.
ANTARES PHARMA, INC.
ANTARES PHARMA, INC. ATTN: PETER J. GRAHAM
100 PRINCETON SOUTH, SUITE 300
EWING, NJ 08628
You are receiving this communication because you
hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may
view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.
Before You Vote
How to Access the Proxy Materials
How To Vote
Please Choose One of the Following Voting Methods
Proxy Materials Available to VIEW or RECEIVE:
FORM 10-K NOTICE AND PROXY STATEMENT
How to View Online:
Have the information that is printed in the box
marked by the arrow following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL
Copy:
If you want to receive a paper or e-mail copy of
these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET: www.proxyvote.com 2) BY
TELEPHONE: 1-800-579-1639
3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send
a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line.
Requests, instructions and other inquiries sent
to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 28, 2020 to facilitate timely delivery.
Vote By Internet:
Before The Meeting:
Go to www.proxyvote.com. Have the information
that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.
During The Meeting:
Go to www.virtualshareholdermeeting.com/ATRS2020.
Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions. Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a
proxy card.
The Board of Directors recommends you vote FOR
ALL on Proposal 1.
1. Election of the Director nominees listed below
as Class I Directors:
Nominees:
01) Leonard S. Jacob, M.D., Ph.D.
02) Peter S. Greenleaf
The Board of Directors recommends you vote FOR
Proposal 2.
2. To hold a non-binding, advisory vote to
approve our named executive officer compensation as disclosed in our proxy statement.
The Board of Directors recommends you vote FOR
Proposal 3.
3. To ratify the appointment of KPMG LLP as our
independent registered public accounting firm for our fiscal year ending December 31, 2020.
NOTE: Such other business as may properly come
before the meeting or any adjournment thereof.
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Sep 2023 to Sep 2024